Skip to main content
. 2022 Dec 19;22:206. doi: 10.1186/s12894-022-01160-y

Table 2.

Mean and median per patient costs (in €) at first and second year after diagnosis, stratified by stage at diagnosis, morphology and procedure

First year Second year* Total*
n Mean (S.D.) Median Mean Rate n Mean (S.D.) Median Mean Rate Mean (S.D.) Median Mean Rate
Stage at diagnosis
 I 90 14,610 (5415) 13,070 88 2427 (3961) 1167 17,037 (6735) 14,237
 II 14 14,503 (4199) 13,242 0.99 14 4891 (10,189) 1048 2.02 19,394 (11,020) 14,290 1.14
 III 30 22,126 (15,052) 13,683 1.51 28 6320 (10,128) 1587 2.60 28,447 (18,343) 15,270 1.67
 IV 14 26,096 (15,845) 24,688 1.79 8 15,397 (12,675) 11,864 6.34 41,494 (23,069) 36,552 2.44
Histology
 Chromophobe 8 13,231 (1002) 13,106 8 1685 (2306) 877 14,917 (2515) 13,983
 Clear cell 94 17,488 (10,577) 13,293 1.32 91 4222 (7087) 1700 2.51 21,709 (12,796) 14,993 1.45
 Non-classified/undifferentiated 2 29,626 (1007) 29,626 2.24 0 29,626 (1007) 29,626 1.99
 Papillary 21 15,331 (8260) 13,350 1.16 20 3552 (6774) 1167 2.11 18,882 (10,790) 14,517 1.27
 Unknown 23 18,095 (11,881) 13,571 1.37 19 5976 (12,039) 1043 3.55 24,070 (17,793) 14,614 1.61
Procedures
 Radical nephrectomy 66 21,394 (13,661) 1198 1.52 58 6410 (9802) 1898 2.85 27,804 (10,591) 16,007 1.70
 Partial nephrectomy 76 14,066 (3220) 13,013 76 2249 (3802) 1144 16,315 (3820) 14,157
 Percutaneous ablation 3 17,885 (7923) 12,623 1.27 3 12,935 (17,499) 591 5.75 30,820 (18,087) 13,215 1.89
 None 3 4127 (2779) 4238 0.29 1 730 (0) 730 0.30 4857 (1604) 4968 0.30
Total 148 17,210 (10,312) 13,335 138 3934 (7609) 1145 21,429 (13,102) 14,606

*Weighted by survival time